Video

High Cost Drug Launches and Specialty Pharmacy

Author(s):

Lauren Santye, Assistant Editor

Kevin James, RPh, MBA, vice president of Payer Strategy at US Bioservices, discusses lessons the specialty industry learned from the impact of high cost drug launches for hepatitis C and high cholesterol.

Kevin James, RPh, MBA, vice president of Payer Strategy at US Bioservices, discusses lessons the specialty industry learned from the impact of high cost drug launches for hepatitis C and high cholesterol.

Related Videos
Image Credit: © Birdland - stock.adobe.com
Image Credit: © alenamozhjer - stock.adobe.com
Pharmacy, Advocacy, Opioid Awareness Month | Image Credit: pikselstock - stock.adobe.com
Image Credit: © Andrey Popov - stock.adobe.com
Pharmacists, Education, Advocacy, Opioid Awareness Month | Image Credit: Jacob Lund - stock.adobe.com
Pharmacy technician working in a pharmacy -- Image credit: sofiko14 | stock.adobe.com
Team of pharmacists -- Image credit: Jacob Lund | stock.adobe.com
Pharmacist assists senior woman in buying medicine in pharmacy - Image credit: Drazen | stock.adobe.com
World Standards Week 2024: US Pharmacopeia’s Achievements and Future Focus in Pharmacy Standards
Pharmacists working in a pharmacy -- Image credit: Drazen | stock.adobe.com
Related Content
Oral Semaglutide, GLP-1, Diabetes, MACE | Image Credit: Chinnapong - stock.adobe.com
October 29th 2024

Oral Semaglutide Reduces Risk of MACE for Patients With Type 2 Diabetes

Ashley Gallagher, Associate Editor
Pharmacy Focus: Oncology Edition- Exploring Pelareorep: A Novel Immunotherapy for Advanced Breast Cancer
October 28th 2024

Pharmacy Focus: Oncology Edition- Exploring Pelareorep: A Novel Immunotherapy for Advanced Breast Cancer

Chronic kidney disease, doctor holding model for treatment urinary system, urology, Estimated glomerular filtration rate eGFR - Image credit: manassanant | stock.adobe.com
October 25th 2024

Zaltenibart Receives FDA Rare Pediatric Disease Designation for C3 Glomerulopathy

Kennedy Ferruggia, Assistant Editor
Pharmacy Focus - Oncology Edition: Advancing Brain Cancer Research and Treatment
September 26th 2024

Pharmacy Focus - Oncology Edition: Advancing Brain Cancer Research and Treatment

Gene therapy -- Image credit: RFBSIP | stock.adobe.com
Published: October 25th 2024 | Updated: October 25th 2024

FDA Grants Orphan Drug Designation to MDL-101 for Congenital Muscular Dystrophy Type 1a

Gillian McGovern, Assistant Editor
Aerobic exercise -- Image credit: Kalim | stock.adobe.com
October 24th 2024

Women Beginning Chemotherapy for Breast Cancer Self-Report Improved Cognitive Function When Participating in Aerobic Exercise

Gillian McGovern, Assistant Editor